Myriad Genetics (MYGN) Plunges After a Partial Supreme Court Victory
June 21, 2013 at 09:50 AM EDT
Shares of diagnostic test maker Myriad Genetics (MYGN) plunged nearly 14% last Friday, after the company received a partial victory in its patent battle over its test for genes associated with breast and ovarian cancer, which ended four years of lit... Read the rest of Myriad Genetics (MYGN) Plunges After a Partial Supreme Court Victory at InvestorGuide.com .
